Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02619669
Title Neoadjuvant Run-In Study With TAK-228 (MLN0128) Followed by Letrozole/TAK-228 (MLN0128) in Women With High-Risk ER+/HER2- Breast Cancer
Recruitment Withdrawn
Gender female
Phase Phase I
Variant Requirements No
Sponsors Dartmouth-Hitchcock Medical Center

Her2-receptor negative breast cancer




Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756 United States Details
*Shaded cells indicate that there was no data available from for the field